STOCK TITAN

Research Solutions Q1 adjusted EBITDA falls 30.3%

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Research Solutions, Inc. (RSSS) reported first-quarter fiscal 2027 revenue of $11.9 million, down from $12.3 million a year earlier as lower transaction revenue outweighed platform growth. Platform revenue was $5.31 million, up 3.7%, while transaction revenue was $6.60 million, down 8.2%. Total annual recurring revenue reached $22.5 million, up 5.7%; B2B ARR rose 11.5%, partly offset by lower B2C ARR.

Gross margin increased to 53.6% from 50.6%, with transaction gross margin rising to 26.7% from 23.8%. Net income was $765,252 versus $749,387, while Adjusted EBITDA fell 30.3% to $1,026,648. Operating expenses rose 3.7% to $5.46 million, primarily due to higher general and administrative costs, including legal and severance, and technology and product development; lower sales and marketing costs and a non-cash recovery of stock-based compensation partly offset the increase. Net cash provided by operating activities was $1,170,609, versus $1,107,119; cash and cash equivalents were $12,586,878 at September 30, 2026.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 1 point

How the balance works

Positive

  • Moderate pointOperating cash flow rose to $1.17 million, from $1.11 million.

Negative

  • Moderate pointAdjusted EBITDA declined 30.3% to $1.03 million year over year.

Filing Explained

For the quarter ended September 30, 2026, cash contingent acquisition consideration for Scite and FIZ was $1,183,906, and $726,714 of common stock was issued for a Scite earnout, increasing the share count and reducing existing holders’ percentage ownership.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Total revenue $11,911,513 Quarter ended September 30, 2026; $12,312,185 in the prior-year quarter, down 3.3%.
B2B ARR $16,460,041 End of period; up 11.5% from the prior-year period.
Total ARR $22,503,820 End of period; up 5.7% from $21,293,669 a year earlier.
Gross margin 53.6% Quarter ended September 30, 2026; 50.6% in the prior-year quarter.
Net income $765,252 Quarter ended September 30, 2026; $749,387 in the prior-year quarter.
Adjusted EBITDA $1,026,648 Quarter ended September 30, 2026; down 30.3% from $1,472,963.
Operating cash flow $1,170,609 Quarter ended September 30, 2026; compared with $1,107,119 in the prior-year quarter.
Cash and cash equivalents $12,586,878 At September 30, 2026; $12,630,283 at June 30, 2026.
annual recurring revenue financial
"The Company defines annual recurring revenue (“ARR”) as the value of contracted Platform subscription recurring revenue"
Annual recurring revenue is the predictable amount of money a company expects to earn each year from ongoing customer subscriptions or contracts. It helps businesses understand how much steady income they can count on, much like a subscription service that charges customers every month or year. This figure is important because it shows the company's stability and growth potential.
Adjusted EBITDA financial
"Adjusted EBITDA is defined as net income (loss), plus interest expense"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
non-GAAP measure financial
"management also considers the non-GAAP measure of Adjusted EBITDA"
A non-GAAP measure is a company-crafted financial metric that adjusts or excludes items from standard accounting numbers to highlight what management sees as the business’s core performance. Investors use these figures like a filtered photo to reveal trends or cash flow drivers that raw accounting totals might hide, but because companies decide which items to remove, these measures should be compared with standard statements to avoid being misled.
active customer accounts financial
"The Company defines active customer accounts as the sum of the total quantity of customers per month"
accreted interest expense financial
"Accreted interest expense"
contingent earnout liability financial
"Contingent earnout liability"
A contingent earnout liability is a recorded obligation a buyer takes on when part of a purchase price will be paid later only if the acquired business hits agreed targets, such as revenue or profit milestones. It matters to investors because it can change a company’s future cash needs and reported liabilities—think of it like buying a car and promising extra payment if it reaches a certain mileage: the promise affects your wallet and balance sheet even before the payment happens.
Total revenue $11,911,513 down 3.3% from $12,312,185
Platform revenue $5,309,780 up 3.7% from $5,120,840
Transaction revenue $6,601,733 down 8.2% from $7,191,345
Total ARR $22,503,820 up 5.7% from $21,293,669
Gross margin 53.6% up from 50.6%
Net income $765,252 up 2.1% from $749,387
Adjusted EBITDA $1,026,648 down 30.3% from $1,472,963
Operating cash flow $1,170,609 compared with $1,107,119 in the prior-year quarter

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What revenue did RSSS report for fiscal Q1 2027?

Research Solutions reported total revenue of $11,911,513 for the three months ended September 30, 2026, compared with $12,312,185 in the prior-year quarter. Platform revenue was $5,309,780, while transaction revenue was $6,601,733.

How much Adjusted EBITDA did RSSS report?

Adjusted EBITDA was $1,026,648 for the quarter ended September 30, 2026, compared with $1,472,963 a year earlier. The company defines this non-GAAP measure as net income or loss plus specified interest, other income or expense, foreign currency, tax, depreciation and amortization, stock-based compensation, and other potential adjustments.

How does RSSS define an active customer account?

Research Solutions defines active customer accounts as the average monthly customer count across the period, with a customer counted in a month if it had at least one transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001386301 0001386301 2026-11-16 2026-11-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report:

(Date of earliest event reported)

 

November 16, 2026

 

 

 

Research Solutions, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

(State or other Jurisdiction of Incorporation)

 

1-39256

  11-3797644
(Commission File Number)   (IRS Employer Identification No.)

 

N/A1

(Address of Principal Executive Offices and zip code)

 

(310) 477-0354

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

 

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨  Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class Trading Symbol(s) Name of each Exchange on which registered
Common stock, $0.001 par value RSSS The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

 

Emerging growth company     ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ¨

 

 

1 In November 2019, we became a fully remote company. Accordingly, we do not currently have principal executive offices. Our mailing address is 10624 E. Eastern Ave., Ste. A-614, Henderson, NV 89052.

 

 

 

 

 

 

Item 2.02 Results of Operations and Financial Condition.

 

On November 16, 2026, the Registrant announced its financial results for the first quarter ended September 30, 2026. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information in this Item 2.02 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits

 

  (d) Exhibits.

 

  Exhibit Number Description

 

99.1Press Release issued November 16, 2026 entitled “Research Solutions Reports First Quarter Fiscal Year 2027 Results”.

 

104Cover Page Interactive Data File (embedded as Inline XBRL document).

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  RESEARCH SOLUTIONS, INC.
     
Date: November 16, 2026 By: /s/ David Kutil
    David Kutil
    Chief Financial Officer

 

 

 

 

Exhibit 99.1

 

FOR IMMEDIATE RELEASE

 

 

 

Research Solutions Reports First Quarter Fiscal Year 2027 Results

 

Reports 11.5% YoY B2B ARR Increase and ARR of $22.5 Million

 

HENDERSON, Nev., November 16, 2026 — Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research workflow platform, reported financial results for its first quarter ended September 30, 2026.

 

Fiscal First Quarter 2027 Summary (compared to prior-year quarter)

 

·B2B ARR grew $1.7 million or 11.5% compared to the first quarter of fiscal 2026 resulting in $16.5 million of ARR. This included AI related ARR of $1.1 million which grew 38% sequentially from the fourth quarter of fiscal 2026.

 

·Platform revenue up 3.7% to $5.3 million. Annual Recurring Revenue (“ARR”) up 5.7% to $22.5 million, which includes approximately $16.5 million of B2B recurring revenue and $6.0 million of B2C recurring revenue.

 

·Total revenue of $11.9 million, compared to $12.3 million.

 

·Gross profit of $6.4 million compared to $6.2 million. Total gross margin improved 300 basis points to 53.6%, driven mainly by the continued platform mix shift and improved transaction margins.

 

·Net income of $765,000, or $0.02 per diluted share, compared to $749,000 or $0.02 per diluted share. Adjusted net income after excluding one-time items was $1.2 million or $0.04 per diluted share.

 

·Adjusted EBITDA of $1.0 million and an adjusted EBITDA margin of 8.6%. Adjusted EBITDA after excluding one-time items was $1.5 million.

 

·Cash flow from operations of $1.2 million compared to $1.1 million in the prior year. The Company ended the quarter with $12.6 million in cash and cash equivalents after paying $1.2 million of the Scite earn-out.

 

“Our continued investment in innovation is expanding how researchers discover, access, and engage with scientific literature,” said Roy W. Olivier, President and CEO of Research Solutions. “Recent launches of Article Galaxy and Scite integrations with ChatGPT, Claude, and Microsoft Copilot bring our capabilities directly into the AI-powered workflows researchers increasingly rely on, making it easier to find trusted evidence and access scholarly content. Platform revenue accounted for 45% of total revenue this quarter, up from 42% a year ago, reflecting our continued transition toward a higher-margin, recurring revenue model. This evolution is strengthening profitability and operating cash flow, enabling us to reinvest in sales capacity and product innovation to accelerate long-term growth.”

 

Fiscal First Quarter 2027 Results

 

Total revenue was $11.9 million, compared to $12.3 million in the year-ago quarter, as increased platform revenue was more than offset by a decrease in transaction revenue.

 

 

 

 

Platform subscription revenue for the quarter was $5.3 million, compared to $5.1 million in the prior-year period. The increase of 11.5% in B2B platform ARR was due to a mix of new logo generation and upsell and cross-sell into existing customers, partially offset by a decline in B2C revenue. The quarter ended with annual recurring revenue of $22.5 million, up 5.7% year-over-year (see the Company’s definition of annual recurring revenue below).

 

Transaction revenue was $6.6 million, compared to $7.2 million in the first quarter of fiscal 2026. The decrease was due to lower paid order volume. The transaction active customer count for the quarter was 1,360, compared to 1,326 customers in the prior-year quarter (see the Company's definition of active customer accounts and transactions below).

 

Total gross margin improved 300 basis points from the prior-year quarter to 53.6%. The increase was primarily driven by the continued revenue mix shift to the higher-margin platforms business and an improvement in transactions gross margin to 26.7% from 23.8%, partially offset by a lower Platforms gross margin on slightly higher hosting and technology costs.

 

Total operating expenses were $5.5 million, compared to $5.3 million in the first quarter of 2026. The increase was primarily related to higher general and administrative expenses, driven by legal and severance costs along with higher technology and product development expense, partially offset by lower sales and marketing expense and a non-cash recovery of stock-based compensation due to restricted stock forfeitures.

 

Other expense for the quarter was approximately $0.1 million compared to $0.2 million in the first quarter of fiscal 2026, primarily due to lower accreted interest expense on the Scite earn-out liability.

 

Net income in the first quarter was $765,000 or $0.02 per diluted share, compared to $749,000, or $0.02 per diluted share, in the prior-year quarter. Adjusted EBITDA was $1.0 million, compared to $1.5 million in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

 

Conference Call

 

Research Solutions President and CEO Roy W. Olivier and CFO David Kutil will host the conference call, followed by a question-and-answer period.

 

Date: Tuesday, November 17, 2026

Time: 9:00 a.m. ET (6:00 a.m. PT)

Dial-in number: 1-203-518-9765

Conference ID: RESEARCH

 

The conference call will be broadcast live and available for replay until December 17, 2026 by dialing 1-412-317-6671 and using the replay ID 11160802, and via the investor relations section of the Company's website at http://researchsolutions.investorroom.com/.

 

 

 

 

Fiscal First Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter

 

   Quarter Ended September 30, 
   2026   2025   Change   % Change 
Revenue:                    
Platforms  $5,309,780   $5,120,840   $188,940    3.7%
Transactions   6,601,733    7,191,345    (589,612)   (8.2)%
Total Revenue   11,911,513    12,312,185    (400,672)   (3.3)%
                     
Gross Profit:                    
Platforms  $4,621,522   $4,510,465   $111,057    2.5%
Transactions   1,759,458    1,714,833    44,625    2.6%
Total Gross Profit   6,380,980    6,225,298    155,682    2.5%
                     
Gross profit as a % of revenue:                    
Platforms   87.0%   88.1%   -1.1%     
Transactions   26.7%   23.8%   2.9%     
Total Gross Profit   53.6%   50.6%   3.0%     
                     
Operating Expenses:                    
Sales and marketing  $1,463,197   $1,666,825   $(203,628)   (12.2)%
Technology and product development   1,665,892    1,410,151    255,741    18.1%
General and administrative   2,225,243    1,675,359    549,884    32.8%
Depreciation and amortization   310,863    316,066    (5,203)   (1.6)%
Stock-based compensation   (196,549)   212,482    (409,031)   (192.5)%
Foreign currency transaction loss (gain)   (8,541)   (17,256)   8,715    50.5%
Total Operating Expenses   5,460,105    5,263,627    196,478    3.7%
Income from operations   920,875    961,671    (40,796)   (4.2)%
                     
Other Income (Expenses):                    
Other income   93,608    126,913    (33,305)   (26.2)%
Accreted interest expense   (149,212)   (317,966)   168,754    53.1%
Provision for income taxes   (100,019)   (21,231)   (78,788)   (371.1)%
Total Other Expenses   (155,623)   (212,284)   56,661    26.7% 
Net income  $765,252   $749,387   $15,865    2.1%
                     
Adjusted EBITDA  $1,026,648   $1,472,963   $(446,315)   (30.3)%

 

   Quarter Ended September 30, 
   2026   2025   Change   % Change 
Platforms:                    
B2B ARR (Annual recurring revenue):                    
Beginning of Period  $16,202,626   $14,197,598   $2,005,028    14.1%
Incremental ARR  257,415    560,874    (303,459)   (54.1)%
End of Period  $16,460,041   $14,758,472   $1,701,569    11.5%
                     
Deployments:                    
Beginning of Period   1,276    1,171    105    9.0%
Incremental Deployments   22    14    8    57.1%
End of Period   1,298    1,185    113    9.5%
                    
ASP (Average sales price):                    
Beginning of Period  $12,698   $12,124   $574    4.7%
End of Period  $12,681   $12,454   $227    1.8%
                     
B2C ARR (Annual recurring revenue):                    
Beginning of Period  $6,342,350   $6,721,356   $(379,006)   (5.6)%
Incremental ARR   (298,571)   (186,159)   (112,412)   NM 
End of Period  $6,043,779   $6,535,197   $(491,418)   (7.5)%
                     
Total ARR (Annualized recurring revenue)  $22,503,820   $21,293,669   $1,210,151    5.7%
                     
Transaction Customers:                    
Corporate customers   981    1,002    (21)   (2.1)%
Academic customers   379    324    55    17.0%
Total customers   1,360    1,326    34    2.6%

 

 

 

Active Customer Accounts, Transactions and Annual Recurring Revenue

 

The Company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.

 

A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.

 

The Company defines annual recurring revenue (“ARR”) as the value of contracted Platform subscription recurring revenue normalized to a one-year period. For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve.

 

Use of Non-GAAP Measure – Adjusted EBITDA

 

Research Solutions’ management evaluates and makes operating decisions using various financial metrics. In addition to the Company’s GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the Company’s operating results.

 

The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other (income) expense, foreign currency transaction (gain) loss, provision for income taxes, depreciation and amortization, stock-based compensation, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):

 

   Quarter Ended September 30, 
   2026   2025   Change   % Change 
Net Income  $765,252   $749,387   $15,865    2.1%
Add (deduct):                    
Other (income) expense   55,604    191,053    (135,449)   (70.9)%
Foreign currency transaction loss (gain)   (8,541)   (17,256)   8,715    50.5%
Provision for income taxes   100,019    21,231    78,788    371.1%
Depreciation and amortization   310,863    316,066    (5,203)   (1.6)%
Stock-based compensation   (196,549)   212,482    (409,031)   (192.5)%
Adjusted EBITDA  $1,026,648   $1,472,963   $(446,315)   (30.3)%

 

About Research Solutions

 

Research Solutions, Inc. (NASDAQ: RSSS) is a vertical SaaS and AI Company that simplifies research workflow for academic institutions, life science companies, and research organizations worldwide. As one of the only publisher-independent marketplaces for scientific, technical, and medical (STM) content, the Company uniquely combines AI-powered tools—including an intelligent research assistant and full-text search capabilities—with seamless access to both open access and paywalled research. The platform enables organizations to discover, access, manage and analyze scientific literature more efficiently, accelerating the pace of scientific discovery. For more information and details, please visit www.researchsolutions.com

 

Important Cautions Regarding Forward-Looking Statements

 

Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, creating long-term value for shareholders and the Company’s prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission.

 

 

 

 

Research Solutions, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets (Unaudited)

 

   September 30,   June 30, 
   2026   2026 
Assets          
Current assets:          
Cash and cash equivalents  $12,586,878   $12,630,283 
Accounts receivable, net of allowance of $89,077 and $103,217, respectively   6,649,615    6,963,040 
Prepaid expenses and other current assets   633,216    689,548 
Prepaid royalties   883,531    411,297 
Total current assets   20,753,240    20,694,168 
           
Non-current assets:          
Property and equipment, net of accumulated depreciation of $1,026,480 and $1,020,241, respectively   62,906    58,671 
Intangible assets, net of accumulated amortization of $4,245,965 and $3,947,231, respectively   8,239,136    8,537,870 
Goodwill   16,372,979    16,372,979 
Deposits and other assets   996    1,030 
Total assets  $45,429,257   $45,664,718 
           
Liabilities and Stockholders’ Equity          
Current liabilities:          
Accounts payable and accrued expenses  $7,075,360   $6,149,480 
Deferred revenue, current portion   10,796,348    11,467,832 
Contingent earnout liability   5,561,906    7,323,314 
Total current liabilities   23,433,614    24,940,626 
           
Non-current liabilities:          
Deferred revenue, long-term portion   7,157    17,245 
Total liabilities   23,440,771    24,957,871 
           
Commitments and contingencies          
           
Stockholders’ equity:          
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding   —    — 
Common stock; $0.001 par value; 100,000,000 shares authorized; 33,553,819 and 33,513,551 shares issued and outstanding, respectively   33,553    33,513 
Additional paid-in capital   43,518,443    42,998,357 
Accumulated deficit   (21,456,373)   (22,221,625)
Accumulated other comprehensive loss   (107,137)   (103,398)
Total stockholders’ equity   21,988,486    20,706,847 
Total liabilities and stockholders’ equity  $45,429,257   $45,664,718 

 

 

 

 

Research Solutions, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations and Comprehensive Income

(Unaudited)

 

   Three Months Ended 
   September 30, 
   2026   2025 
Revenue:          
Platforms  $5,309,780   $5,120,840 
Transactions   6,601,733    7,191,345 
Total revenue   11,911,513    12,312,185 
           
Cost of revenue:          
Platforms   688,258    610,375 
Transactions   4,842,275    5,476,512 
Total cost of revenue   5,530,533    6,086,887 
Gross profit   6,380,980    6,225,298 
           
Operating expenses:          
Selling, general and administrative   5,149,242    4,947,561 
Depreciation and amortization   310,863    316,066 
Total operating expenses   5,460,105    5,263,627 
           
Income from operations   920,875    961,671 
           
Other income   93,608    126,913 
Accreted interest expense   (149,212)   (317,966)
           
Income before provision for income taxes   865,271    770,618 
Provision for income taxes   (100,019)   (21,231)
           
Net income   765,252    749,387 
           
Other comprehensive income (loss):          
Foreign currency translation   (3,739)   967 
Comprehensive income  $761,513   $750,354 
           
Basic income per common share:          
Net income per share  $0.02   $0.02 
Weighted average common shares outstanding   32,644,399    31,234,875 
           
Diluted income per common share:          
Net income per share  $0.02   $0.02 
Weighted average common shares outstanding   32,916,413    32,070,121 

 

 

 

 

Research Solutions, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   Three Months Ended 
   September 30, 
   2026   2025 
Cash flow from operating activities:          
Net income  $765,252   $749,387 
Adjustment to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization   310,863    316,066 
Stock options expense   90,556    58,706 
Restricted common stock expense (recovery due to forfeitures)   (287,105)   153,776 
Accreted interest expense   149,212    317,966 
Changes in operating assets and liabilities:          
Accounts receivable   313,425    292,053 
Prepaid expenses and other current assets   56,332    (140,004)
Prepaid royalties   (472,234)   (79,513)
Accounts payable and accrued expenses   925,880    158,728 
Deferred revenue   (681,572)   (720,046)
Net cash provided by operating activities   1,170,609    1,107,119 
           
Cash flow from investing activities:          
Purchase of property and equipment   (17,050)   (17,539)
Net cash used in investing activities   (17,050)   (17,539)
           
Cash flow from financing activities:          
Common stock repurchase   (10,039)   (23,387)
Payment of contingent acquisition consideration - Scite and FIZ   (1,183,906)   (1,337,857)
Net cash used in financing activities   (1,193,945)   (1,361,244)
           
Effect of exchange rate changes   (3,019)   115 
Net decrease in cash and cash equivalents   (43,405)   (271,549)
Cash and cash equivalents, beginning of period   12,630,283    12,227,312 
Cash and cash equivalents, end of period  $12,586,878   $11,955,763 
           
Supplemental disclosures of cash flow information:          
Cash paid for income taxes  $100,019   $21,231 
           
Non-cash investing and financing activities:          
Contingent consideration accrual on asset acquisition  $—   $29,117 
Common stock issued for Scite earnout payment  $726,714   $726,714 

 

Contact

 

Steven Hooser or John Beisler

 

Three Part Advisors

(214) 872-2710

shooser@threepa.com; jbeisler@threepa.com

 

# # #

 

 

 

Filing Exhibits & Attachments

4 documents

Keep reading